{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T23:50:55Z","timestamp":1789861855161,"version":"4.0.1"},"reference-count":58,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2013,4,19]],"date-time":"2013-04-19T00:00:00Z","timestamp":1366329600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Blood Cancer Journal"],"DOI":"10.1038\/bcj.2013.10","type":"journal-article","created":{"date-parts":[[2013,4,19]],"date-time":"2013-04-19T13:17:29Z","timestamp":1366377449000},"page":"e111-e111","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["Loss of TCR-beta F1 and\/or EZRIN expression is associated with unfavorable prognosis in nodal peripheral T-cell lymphomas"],"prefix":"10.1038","volume":"3","author":[{"given":"S M","family":"Rodr\u00edguez-Pinilla","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M E C","family":"S\u00e1nchez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J","family":"Rodr\u00edguez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J F","family":"Garc\u00eda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B","family":"S\u00e1nchez-Espiridi\u00f3n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L F","family":"Lamana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G","family":"Sosa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J C","family":"Rivero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J","family":"Men\u00e1rguez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I B","family":"G\u00f3mez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F I","family":"Camacho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P R","family":"Guillen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C P S","family":"Ordu\u00f1a","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G","family":"Rodr\u00edguez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C","family":"Barrionuevo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R","family":"Franco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Mollejo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J F","family":"Marco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R D","family":"de Otazu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M A","family":"Piris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2013,4,19]]},"reference":[{"key":"BFbcj201310_CR1","doi-asserted-by":"publisher","first-page":"1255","DOI":"10.1182\/blood-2005-03-1306","volume":"107","author":"MA Rizvi","year":"2006","unstructured":"Rizvi MA, Evens AM, Tallman MS, Nelson BP, Rosen ST . T-cell non-Hodgkin lymphoma. Blood 2006; 107: 1255\u20131264.","journal-title":"Blood"},{"key":"BFbcj201310_CR2","doi-asserted-by":"publisher","first-page":"4124","DOI":"10.1200\/JCO.2008.16.4558","volume":"26","author":"J Vose","year":"2008","unstructured":"Vose J, Armitage J, Weisenburger D . International peripheral T-cell and natural killer\/T-cell lymphoma study: pathology findings and clinical outcomes. J Clin Oncol 2008; 26: 4124\u20134130.","journal-title":"J Clin Oncol"},{"key":"BFbcj201310_CR3","doi-asserted-by":"publisher","first-page":"1560","DOI":"10.1038\/sj.onc.1209178","volume":"25","author":"B Ballester","year":"2006","unstructured":"Ballester B, Ramuz O, Gisselbrecht C, Doucet G, Loi L, Loriod B et al. Gene expression profiling identifies molecular subgroups among nodal peripheral T-cell lymphomas. Oncogene 2006; 25: 1560\u20131570.","journal-title":"Oncogene"},{"key":"BFbcj201310_CR4","doi-asserted-by":"publisher","first-page":"4952","DOI":"10.1182\/blood-2006-10-055145","volume":"109","author":"L de Leval","year":"2007","unstructured":"de Leval L, Rickman DS, Thielen C, Reynies A, Huang YL, Delsol G et al. The gene expression profile of nodal peripheral T-cell lymphoma demonstrates a molecular link between angioimmunoblastic T-cell lymphoma (AITL) and follicular helper T (TFH) cells. Blood 2007; 109: 4952\u20134963.","journal-title":"Blood"},{"key":"BFbcj201310_CR5","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1111\/j.0105-2896.2006.00343.x","volume":"209","author":"I Aifantis","year":"2006","unstructured":"Aifantis I, Mandal M, Sawai K, Ferrando A, Vilimas T . Regulation of T-cell progenitor survival and cell-cycle entry by the pre-T-cell receptor. Immunol Rev 2006; 209: 159\u2013169.","journal-title":"Immunol Rev"},{"key":"BFbcj201310_CR6","doi-asserted-by":"publisher","first-page":"18939","DOI":"10.1073\/pnas.1013230107","volume":"107","author":"T Serwold","year":"2010","unstructured":"Serwold T, Hochedlinger K, Swindle J, Hedgpeth J, Jaenisch R, Weissman IL . T-cell receptor-driven lymphomagenesis in mice derived from a reprogrammed T cell. Proc Natl Acad Sci USA 2010; 107: 18939\u201318943.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFbcj201310_CR7","doi-asserted-by":"publisher","first-page":"3834","DOI":"10.1172\/JCI37210","volume":"121","author":"X Wang","year":"2011","unstructured":"Wang X, Werneck MB, Wilson BG, Kim HJ, Kluk MJ, Thom CS et al. TCR-dependent transformation of mature memory phenotype T cells in mice. J Clin Invest 2011; 121: 3834\u20133845.","journal-title":"J Clin Invest"},{"key":"BFbcj201310_CR8","doi-asserted-by":"publisher","first-page":"1031","DOI":"10.1084\/jem.20092042","volume":"207","author":"K Pechloff","year":"2010","unstructured":"Pechloff K, Holch J, Ferch U, Schweneker M, Brunner K, Kremer M et al. The fusion kinase ITK-SYK mimics a T cell receptor signal and drives oncogenesis in conditional mouse models of peripheral T cell lymphoma. J Exp Med 2010; 207: 1031\u20131044.","journal-title":"J Exp Med"},{"key":"BFbcj201310_CR9","doi-asserted-by":"publisher","first-page":"1139","DOI":"10.1038\/leu.2008.77","volume":"22","author":"AL Feldman","year":"2008","unstructured":"Feldman AL, Sun DX, Law ME, Novak AJ, Attygalle AD, Thorland EC et al. Overexpression of Syk tyrosine kinase in peripheral T-cell lymphomas. Leukemia 2008; 22: 1139\u20131143.","journal-title":"Leukemia"},{"key":"BFbcj201310_CR10","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1038\/leu.2009.198","volume":"24","author":"RA Wilcox","year":"2010","unstructured":"Wilcox RA, Sun DX, Novak A, Dogan A, Ansell SM, Feldman AL . Inhibition of Syk protein tyrosine kinase induces apoptosis and blocks proliferation in T-cell non-Hodgkin's lymphoma cell lines. Leukemia 2010; 24: 229\u2013232.","journal-title":"Leukemia"},{"key":"BFbcj201310_CR11","doi-asserted-by":"publisher","first-page":"1697","DOI":"10.3324\/haematol.2009.021428","volume":"95","author":"E Geissinger","year":"2010","unstructured":"Geissinger E, Sadler P, Roth S, Grieb T, Puppe B, Muller N et al. Disturbed expression of the T-cell receptor\/CD3 complex and associated signaling molecules in CD30+ T-cell lymphoproliferations. Haematologica 2010; 95: 1697\u20131704.","journal-title":"Haematologica"},{"key":"BFbcj201310_CR12","doi-asserted-by":"publisher","first-page":"5496","DOI":"10.1182\/blood-2008-01-134270","volume":"111","author":"KJ Savage","year":"2008","unstructured":"Savage KJ, Harris NL, Vose JM, Ullrich F, Jaffe ES, Connors JM et al. ALK- anaplastic large-cell lymphoma is clinically and immunophenotypically different from both ALK+ ALCL and peripheral T-cell lymphoma, not otherwise specified: report from the International Peripheral T-Cell Lymphoma Project. Blood 2008; 111: 5496\u20135504.","journal-title":"Blood"},{"key":"BFbcj201310_CR13","doi-asserted-by":"publisher","first-page":"3358","DOI":"10.1182\/blood-2004-03-1037","volume":"104","author":"I Bonzheim","year":"2004","unstructured":"Bonzheim I, Geissinger E, Roth S, Zettl A, Marx A, Rosenwald A et al. Anaplastic large cell lymphomas lack the expression of T-cell receptor molecules or molecules of proximal T-cell receptor signaling. Blood 2004; 104: 3358\u20133360.","journal-title":"Blood"},{"key":"BFbcj201310_CR14","doi-asserted-by":"publisher","first-page":"7990","DOI":"10.1038\/sj.onc.1208074","volume":"23","author":"EH Palacios","year":"2004","unstructured":"Palacios EH, Weiss A . Function of the Src-family kinases, Lck and Fyn, in T-cell development and activation. Oncogene 2004; 23: 7990\u20138000.","journal-title":"Oncogene"},{"key":"BFbcj201310_CR15","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1111\/j.1600-065X.2009.00843.x","volume":"232","author":"CS Guy","year":"2009","unstructured":"Guy CS, Vignali DA . Organization of proximal signal initiation at the TCR:CD3 complex. Immunol Rev 2009; 232: 7\u201321.","journal-title":"Immunol Rev"},{"key":"BFbcj201310_CR16","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1083\/jcb.200707199","volume":"179","author":"T Ilani","year":"2007","unstructured":"Ilani T, Khanna C, Zhou M, Veenstra TD, Bretscher A . Immune synapse formation requires ZAP-70 recruitment by ezrin and CD43 removal by moesin. J Cell Biol 2007; 179: 733\u2013746.","journal-title":"J Cell Biol"},{"key":"BFbcj201310_CR17","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.4049\/jimmunol.182.2.1021","volume":"182","author":"MH Shaffer","year":"2009","unstructured":"Shaffer MH, Dupree RS, Zhu P, Saotome I, Schmidt RF, McClatchey AI et al. Ezrin and moesin function together to promote T cell activation. J Immunol 2009; 182: 1021\u20131032.","journal-title":"J Immunol"},{"key":"BFbcj201310_CR18","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1007\/s11899-009-0030-5","volume":"4","author":"HM O'Leary","year":"2009","unstructured":"O'Leary HM, Savage KJ . Update on the World Health Organization classification of peripheral T-cell lymphomas. Curr Hematol Malig Rep 2009; 4: 227\u2013235.","journal-title":"Curr Hematol Malig Rep"},{"key":"BFbcj201310_CR19","volume-title":"WHO classification of Tumours and Haematopoietic and Lymphoid Tissues","author":"SHCE Swerdlow","year":"2008","unstructured":"Swerdlow SHCE, Harris NL, Pileri SA, Stein H, Thiele J, Vardiman JW . WHO classification of Tumours and Haematopoietic and Lymphoid Tissues. IARC: Lyon, France, 2008."},{"key":"BFbcj201310_CR20","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1182\/blood-2002-04-1128","volume":"101","author":"JF Garcia","year":"2003","unstructured":"Garcia JF, Camacho FI, Morente M, Fraga M, Montalban C, Alvaro T et al. Hodgkin and Reed-Sternberg cells harbor alterations in the major tumor suppressor pathways and cell-cycle checkpoints: analyses using tissue microarrays. Blood 2003; 101: 681\u2013689.","journal-title":"Blood"},{"key":"BFbcj201310_CR21","doi-asserted-by":"publisher","first-page":"2472","DOI":"10.1200\/JCO.2005.03.6327","volume":"24","author":"P Went","year":"2006","unstructured":"Went P, Agostinelli C, Gallamini A, Piccaluga PP, Ascani S, Sabattini E et al. Marker expression in peripheral T-cell lymphoma: a proposed clinical-pathologic prognostic score. J Clin Oncol 2006; 24: 2472\u20132479.","journal-title":"J Clin Oncol"},{"key":"BFbcj201310_CR22","doi-asserted-by":"publisher","first-page":"2474","DOI":"10.1182\/blood-2003-09-3080","volume":"103","author":"A Gallamini","year":"2004","unstructured":"Gallamini A, Stelitano C, Calvi R, Bellei M, Mattei D, Vitolo U et al. Peripheral T-cell lymphoma unspecified (PTCL-U): a new prognostic model from a retrospective multicentric clinical study. Blood 2004; 103: 2474\u20132479.","journal-title":"Blood"},{"key":"BFbcj201310_CR23","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1093\/annonc\/mdq359","volume":"22","author":"G Gutierrez-Garcia","year":"2010","unstructured":"Gutierrez-Garcia G, Garcia-Herrera A, Cardesa T, Martinez A, Villamor N, Ghita G et al. Comparison of four prognostic scores in peripheral T-cell lymphoma. Ann Oncol 2010; 22: 397\u2013404.","journal-title":"Ann Oncol"},{"key":"BFbcj201310_CR24","doi-asserted-by":"publisher","first-page":"3402","DOI":"10.1182\/blood-2010-09-310342","volume":"117","author":"DD Weisenburger","year":"2011","unstructured":"Weisenburger DD, Savage KJ, Harris NL, Gascoyne RD, Jaffe ES, MacLennan KA et al. Peripheral T-cell lymphoma, not otherwise specified: a report of 340 cases from the International Peripheral T-cell Lymphoma Project. Blood 2011; 117: 3402\u20133408.","journal-title":"Blood"},{"key":"BFbcj201310_CR25","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1146\/annurev.iy.06.040188.003213","volume":"6","author":"H Clevers","year":"1988","unstructured":"Clevers H, Alarcon B, Wileman T, Terhorst C . The T cell receptor\/CD3 complex: a dynamic protein ensemble. Annu Rev Immunol 1988; 6: 629\u2013662.","journal-title":"Annu Rev Immunol"},{"key":"BFbcj201310_CR26","doi-asserted-by":"publisher","first-page":"5103","DOI":"10.1182\/blood-2008-04-150748","volume":"112","author":"JM Tjon","year":"2008","unstructured":"Tjon JM, Verbeek WH, Kooy-Winkelaar YM, Nguyen BH, van der Slik AR, Thompson A et al. Defective synthesis or association of T-cell receptor chains underlies loss of surface T-cell receptor-CD3 expression in enteropathy-associated T-cell lymphoma. Blood 2008; 112: 5103\u20135110.","journal-title":"Blood"},{"key":"BFbcj201310_CR27","doi-asserted-by":"publisher","first-page":"1374","DOI":"10.1038\/onc.2009.417","volume":"29","author":"WC Kuo","year":"2010","unstructured":"Kuo WC, Yang KT, Hsieh SL, Lai MZ . Ezrin is a negative regulator of death receptor-induced apoptosis. Oncogene 2010; 29: 1374\u20131383.","journal-title":"Oncogene"},{"key":"BFbcj201310_CR28","doi-asserted-by":"publisher","first-page":"1681","DOI":"10.1002\/pmic.200500417","volume":"6","author":"NM Verrills","year":"2006","unstructured":"Verrills NM, Liem NL, Liaw TY, Hood BD, Lock RB, Kavallaris M . Proteomic analysis reveals a novel role for the actin cytoskeleton in vincristine resistant childhood leukemia--an in vivo study. Proteomics 2006; 6: 1681\u20131694.","journal-title":"Proteomics"},{"key":"BFbcj201310_CR29","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1083\/jcb.200811059","volume":"185","author":"P Lajoie","year":"2009","unstructured":"Lajoie P, Goetz JG, Dennis JW, Nabi IR . Lattices, rafts, and scaffolds: domain regulation of receptor signaling at the plasma membrane. J Cell Biol 2009; 185: 381\u2013385.","journal-title":"J Cell Biol"},{"key":"BFbcj201310_CR30","doi-asserted-by":"publisher","first-page":"1204","DOI":"10.1182\/blood-2004-03-1222","volume":"105","author":"H Sasaki","year":"2005","unstructured":"Sasaki H, Nishikata I, Shiraga T, Akamatsu E, Fukami T, Hidaka T et al. Overexpression of a cell adhesion molecule, TSLC1, as a possible molecular marker for acute-type adult T-cell leukemia. Blood 2005; 105: 1204\u20131213.","journal-title":"Blood"},{"key":"BFbcj201310_CR31","doi-asserted-by":"publisher","first-page":"10117","DOI":"10.1074\/jbc.M609157200","volume":"282","author":"K Ohnuma","year":"2007","unstructured":"Ohnuma K, Uchiyama M, Yamochi T, Nishibashi K, Hosono O, Takahashi N et al. Caveolin-1 triggers T-cell activation via CD26 in association with CARMA1. J Biol Chem 2007; 282: 10117\u201310131.","journal-title":"J Biol Chem"},{"key":"BFbcj201310_CR32","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1016\/j.cub.2009.12.035","volume":"20","author":"A Li","year":"2010","unstructured":"Li A, Dawson JC, Forero-Vargas M, Spence HJ, Yu X, Konig I et al. The actin-bundling protein fascin stabilizes actin in invadopodia and potentiates protrusive invasion. Curr Biol 2010; 20: 339\u2013345.","journal-title":"Curr Biol"},{"key":"BFbcj201310_CR33","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1002\/bies.10070","volume":"24","author":"N Kureishy","year":"2002","unstructured":"Kureishy N, Sapountzi V, Prag S, Anilkumar N, Adams JC . Fascins, and their roles in cell structure and function. Bioessays 2002; 24: 350\u2013361.","journal-title":"Bioessays"},{"key":"BFbcj201310_CR34","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1097\/PAI.0b013e3181a307f7","volume":"18","author":"P Bhargava","year":"2010","unstructured":"Bhargava P, Pantanowitz L, Pinkus GS, Pinkus JL, Paessler ME, Roullet M et al. Utility of fascin and JunB in distinguishing nodular lymphocyte predominant from classical lymphocyte-rich Hodgkin lymphoma. Appl Immunohistochem Mol Morphol 2010; 18: 16\u201323.","journal-title":"Appl Immunohistochem Mol Morphol"},{"key":"BFbcj201310_CR35","doi-asserted-by":"crossref","first-page":"742","DOI":"10.5858\/2007-131-742-FEIDLB","volume":"131","author":"NA Bakshi","year":"2007","unstructured":"Bakshi NA, Finn WG, Schnitzer B, Valdez R, Ross CW . Fascin expression in diffuse large B-cell lymphoma, anaplastic large cell lymphoma, and classical Hodgkin lymphoma. Arch Pathol Lab Med 2007; 131: 742\u2013747.","journal-title":"Arch Pathol Lab Med"},{"key":"BFbcj201310_CR36","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/j.yexcr.2005.09.018","volume":"312","author":"M Lan","year":"2006","unstructured":"Lan M, Kojima T, Murata M, Osanai M, Takano K, Chiba H et al. Phosphorylation of ezrin enhances microvillus length via a p38 MAP-kinase pathway in an immortalized mouse hepatic cell line. Exp Cell Res 2006; 312: 111\u2013120.","journal-title":"Exp Cell Res"},{"key":"BFbcj201310_CR37","doi-asserted-by":"publisher","first-page":"989","DOI":"10.1158\/0008-5472.CAN-07-2017","volume":"68","author":"D Sarrio","year":"2008","unstructured":"Sarrio D, Rodriguez-Pinilla SM, Hardisson D, Cano A, Moreno-Bueno G, Palacios J . Epithelial-mesenchymal transition in breast cancer relates to the basal-like phenotype. Cancer Res 2008; 68: 989\u2013997.","journal-title":"Cancer Res"},{"key":"BFbcj201310_CR38","doi-asserted-by":"publisher","first-page":"1212","DOI":"10.1002\/ijc.24400","volume":"125","author":"N Isohata","year":"2009","unstructured":"Isohata N, Aoyagi K, Mabuchi T, Daiko H, Fukaya M, Ohta H et al. Hedgehog and epithelial-mesenchymal transition signaling in normal and malignant epithelial cells of the esophagus. Int J Cancer 2009; 125: 1212\u20131221.","journal-title":"Int J Cancer"},{"key":"BFbcj201310_CR39","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1002\/emmm.200900039","volume":"1","author":"F Varnat","year":"2009","unstructured":"Varnat F, Duquet A, Malerba M, Zbinden M, Mas C, Gervaz P et al. Human colon cancer epithelial cells harbour active HEDGEHOG-GLI signalling that is essential for tumour growth, recurrence, metastasis and stem cell survival and expansion. EMBO Mol Med 2009; 1: 338\u2013351.","journal-title":"EMBO Mol Med"},{"key":"BFbcj201310_CR40","doi-asserted-by":"publisher","first-page":"2550","DOI":"10.1158\/0008-5472.CAN-08-1808","volume":"69","author":"RR Singh","year":"2009","unstructured":"Singh RR, Cho-Vega JH, Davuluri Y, Ma S, Kasbidi F, Milito C et al. Sonic hedgehog signaling pathway is activated in ALK-positive anaplastic large cell lymphoma. Cancer Res 2009; 69: 2550\u20132558.","journal-title":"Cancer Res"},{"key":"BFbcj201310_CR41","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.1038\/leu.2010.35","volume":"24","author":"RR Singh","year":"2010","unstructured":"Singh RR, Kim JE, Davuluri Y, Drakos E, Cho-Vega JH, Amin HM et al. Hedgehog signaling pathway is activated in diffuse large B-cell lymphoma and contributes to tumor cell survival and proliferation. Leukemia 2010; 24: 1025\u20131036.","journal-title":"Leukemia"},{"key":"BFbcj201310_CR42","doi-asserted-by":"publisher","first-page":"834","DOI":"10.1038\/sj.cdd.4401845","volume":"13","author":"ML Schmitz","year":"2006","unstructured":"Schmitz ML, Krappmann D . Controlling NF-kappaB activation in T cells by costimulatory receptors. Cell Death Differ 2006; 13: 834\u2013842.","journal-title":"Cell Death Differ"},{"key":"BFbcj201310_CR43","doi-asserted-by":"publisher","first-page":"826","DOI":"10.1038\/sj.cdd.4401856","volume":"13","author":"R Weil","year":"2006","unstructured":"Weil R, Israel A . Deciphering the pathway from the TCR to NF-kappaB. Cell Death Differ 2006; 13: 826\u2013833.","journal-title":"Cell Death Differ"},{"key":"BFbcj201310_CR44","doi-asserted-by":"publisher","first-page":"7628","DOI":"10.1158\/0008-5472.CAN-05-0925","volume":"65","author":"M Watanabe","year":"2005","unstructured":"Watanabe M, Sasaki M, Itoh K, Higashihara M, Umezawa K, Kadin ME et al. JunB induced by constitutive CD30-extracellular signal-regulated kinase 1\/2 mitogen-activated protein kinase signaling activates the CD30 promoter in anaplastic large cell lymphoma and Reed-Sternberg cells of Hodgkin lymphoma. Cancer Res 2005; 65: 7628\u20137634.","journal-title":"Cancer Res"},{"key":"BFbcj201310_CR45","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1016\/j.it.2004.03.008","volume":"25","author":"G Bonizzi","year":"2004","unstructured":"Bonizzi G, Karin M . The two NF-kappaB activation pathways and their role in innate and adaptive immunity. Trends Immunol 2004; 25: 280\u2013288.","journal-title":"Trends Immunol"},{"key":"BFbcj201310_CR46","doi-asserted-by":"crossref","first-page":"2700","DOI":"10.1182\/blood-2006-07-025809","volume":"109","author":"PJ Jost","year":"2007","unstructured":"Jost PJ, Ruland J . Aberrant NF-kappaB signaling in lymphoma: mechanisms, consequences, and therapeutic implications. Blood 2007; 109: 2700\u20132707.","journal-title":"Blood"},{"key":"BFbcj201310_CR47","doi-asserted-by":"publisher","first-page":"2254","DOI":"10.1038\/sj.leu.2403960","volume":"19","author":"B Martinez-Delgado","year":"2005","unstructured":"Martinez-Delgado B, Cuadros M, Honrado E, Ruiz de la Parte A, Roncador G, Alves J et al. Differential expression of NF-kappaB pathway genes among peripheral T-cell lymphomas. Leukemia 2005; 19: 2254\u20132263.","journal-title":"Leukemia"},{"key":"BFbcj201310_CR48","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1038\/ni.1837","volume":"11","author":"S Crotty","year":"2010","unstructured":"Crotty S, Johnston RJ, Schoenberger SP . Effectors and memories: Bcl-6 and Blimp-1 in T and B lymphocyte differentiation. Nat Immunol 2010; 11: 114\u2013120.","journal-title":"Nat Immunol"},{"key":"BFbcj201310_CR49","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1038\/nrc780","volume":"2","author":"M Karin","year":"2002","unstructured":"Karin M, Cao Y, Greten FR, Li ZW . NF-kappaB in cancer: from innocent bystander to major culprit. Nat Rev Cancer 2002; 2: 301\u2013310.","journal-title":"Nat Rev Cancer"},{"key":"BFbcj201310_CR50","doi-asserted-by":"publisher","first-page":"2354","DOI":"10.1182\/blood-2005-06-2536","volume":"107","author":"A Sors","year":"2006","unstructured":"Sors A, Jean-Louis F, Pellet C, Laroche L, Dubertret L, Courtois G et al. Down-regulating constitutive activation of the NF-kappaB canonical pathway overcomes the resistance of cutaneous T-cell lymphoma to apoptosis. Blood 2006; 107: 2354\u20132363.","journal-title":"Blood"},{"key":"BFbcj201310_CR51","doi-asserted-by":"publisher","first-page":"3867","DOI":"10.1182\/blood-2007-08-108654","volume":"111","author":"WL Zhao","year":"2008","unstructured":"Zhao WL, Liu YY, Zhang QL, Wang L, Leboeuf C, Zhang YW et al. PRDM1 is involved in chemoresistance of T-cell lymphoma and down-regulated by the proteasome inhibitor. Blood 2008; 111: 3867\u20133871.","journal-title":"Blood"},{"key":"BFbcj201310_CR52","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1007\/s00277-008-0544-2","volume":"88","author":"Y Lee","year":"2009","unstructured":"Lee Y, Uhm JE, Lee HY, Park MJ, Kim H, Oh SJ et al. Clinical features and prognostic factors of patients with \u2018peripheral T cell lymphoma, unspecified\u2019. Ann Hematol 2009; 88: 111\u2013119.","journal-title":"Ann Hematol"},{"key":"BFbcj201310_CR53","doi-asserted-by":"publisher","first-page":"2334","DOI":"10.1038\/sj.onc.1204416","volume":"20","author":"EF Wagner","year":"2001","unstructured":"Wagner EF . AP-1\u2013Introductory remarks. Oncogene 2001; 20: 2334\u20132335.","journal-title":"Oncogene"},{"key":"BFbcj201310_CR54","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1111\/j.1600-0560.2007.00924.x","volume":"35","author":"X Mao","year":"2008","unstructured":"Mao X, Orchard G, Mitchell TJ, Oyama N, Russell-Jones R, Vermeer MH et al. A genomic and expression study of AP-1 in primary cutaneous T-cell lymphoma: evidence for dysregulated expression of JUNB and JUND in MF and SS. J Cutan Pathol 2008; 35: 899\u2013910.","journal-title":"J Cutan Pathol"},{"key":"BFbcj201310_CR55","doi-asserted-by":"publisher","first-page":"1922","DOI":"10.4049\/jimmunol.169.4.1922","volume":"169","author":"FH Vasanwala","year":"2002","unstructured":"Vasanwala FH, Kusam S, Toney LM, Dent AL . Repression of AP-1 function: a mechanism for the regulation of Blimp-1 expression and B lymphocyte differentiation by the B cell lymphoma-6 protooncogene. J Immunol 2002; 169: 1922\u20131929.","journal-title":"J Immunol"},{"key":"BFbcj201310_CR56","doi-asserted-by":"publisher","first-page":"1042","DOI":"10.1182\/blood-2002-11-3574","volume":"102","author":"L Tracey","year":"2003","unstructured":"Tracey L, Villuendas R, Dotor AM, Spiteri I, Ortiz P, Garcia JF et al. Mycosis fungoides shows concurrent deregulation of multiple genes involved in the TNF signaling pathway: an expression profile study. Blood 2003; 102: 1042\u20131050.","journal-title":"Blood"},{"key":"BFbcj201310_CR57","doi-asserted-by":"publisher","first-page":"3321","DOI":"10.1200\/JCO.2006.09.4474","volume":"25","author":"M Cuadros","year":"2007","unstructured":"Cuadros M, Dave SS, Jaffe ES, Honrado E, Milne R, Alves J et al. Identification of a proliferation signature related to survival in nodal peripheral T-cell lymphomas. J Clin Oncol 2007; 25: 3321\u20133329.","journal-title":"J Clin Oncol"},{"key":"BFbcj201310_CR58","doi-asserted-by":"crossref","first-page":"2650","DOI":"10.1182\/blood.V78.10.2650.2650","volume":"78","author":"EK Waller","year":"1991","unstructured":"Waller EK, Kamel OW, Cleary ML, Majumdar AS, Schick MR, Lieberman M et al. Growth of primary T-cell non-Hodgkin's lymphomata in SCID-hu mice: requirement for a human lymphoid microenvironment. Blood 1991; 78: 2650\u20132665.","journal-title":"Blood"}],"container-title":["Blood Cancer Journal"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/bcj201310.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/bcj201310","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/bcj201310.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,5]],"date-time":"2023-01-05T22:49:40Z","timestamp":1672958980000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/bcj201310"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,4,19]]},"references-count":58,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2013,4]]}},"alternative-id":["BFbcj201310"],"URL":"https:\/\/doi.org\/10.1038\/bcj.2013.10","relation":{},"ISSN":["2044-5385"],"issn-type":[{"value":"2044-5385","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,4,19]]},"assertion":[{"value":"25 January 2013","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 February 2013","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 February 2013","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 April 2013","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}